These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31520223)

  • 1. Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells.
    Wu D; Chen Y; Wen S; Wen Y; Wang R; Zhang Q; Qin G; Yi H; Wu M; Lu L; Tao X; Deng X
    Nanoscale Res Lett; 2019 Sep; 14(1):314. PubMed ID: 31520223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles.
    Tao X; Xie Y; Zhang Q; Qiu X; Yuan L; Wen Y; Li M; Yang X; Tao T; Xie M; Lv Y; Wang Q; Feng X
    Nanomaterials (Basel); 2016 Sep; 6(9):. PubMed ID: 28335293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination.
    Fonseca NA; Gomes-da-Silva LC; Moura V; Simões S; Moreira JN
    J Control Release; 2014 Dec; 196():122-31. PubMed ID: 25305563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting the proliferation, migration and invasion of triple negative breast cancer cells through anti-tumor human serum albumin nanoparticles loading aziditaxel as a novel taxane derivative.
    Chen LQ; Zhang ZM; Huang W; Gao ZG; Fang WS; Jin MJ; Yu L
    Pharmazie; 2017 Mar; 72(3):152-160. PubMed ID: 29442050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge.
    Yuan L; Cao Y; Luo Q; Yang W; Wu X; Yang X; Wu D; Tan S; Qin G; Zhou J; Zeng Y; Chen X; Tao X; Zhang Q
    Nanoscale Res Lett; 2018 Oct; 13(1):317. PubMed ID: 30306404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
    Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Action of Benzyl Isothiocyanate and Sorafenib in a Nanoparticle Delivery System for Enhanced Triple-Negative Breast Cancer Treatment.
    Wang Q; Cheng N; Wang W; Bao Y
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone.
    Chen Y; Wu D; Zhong W; Kuang S; Luo Q; Song L; He L; Feng X; Tao X
    Nanomaterials (Basel); 2018 Jul; 8(7):. PubMed ID: 29966380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy.
    Son S; Shin S; Rao NV; Um W; Jeon J; Ko H; Deepagan VG; Kwon S; Lee JY; Park JH
    Int J Biol Macromol; 2018 Apr; 110():406-415. PubMed ID: 29055700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy.
    Song L; Tao X; Lin L; Chen C; Yao H; He G; Zou G; Cao Z; Yan S; Lu L; Yi H; Wu D; Tan S; Ouyang W; Dai Z; Deng X
    ACS Appl Mater Interfaces; 2018 Feb; 10(8):7022-7030. PubMed ID: 29405062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Long-Circulating and Fusogenic Liposomes Co-encapsulating Paclitaxel and Doxorubicin in Synergistic Ratio for the Treatment of Breast Cancer.
    Roque MC; Franco MS; Vilela JMC; Andrade MS; de Barros ALB; Leite EA; Oliveira MC
    Curr Drug Deliv; 2019; 16(9):829-838. PubMed ID: 31622204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capsanthin-Loaded Micelles: Preparation, Characterization and
    Shanmugham V; Subban R
    Food Technol Biotechnol; 2022 Sep; 60(3):350-360. PubMed ID: 36320357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy.
    Bhargava-Shah A; Foygel K; Devulapally R; Paulmurugan R
    Nanomedicine (Lond); 2016 Feb; 11(3):235-47. PubMed ID: 26787319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier.
    Yang W; Wang M; Ma L; Li H; Huang L
    Carbohydr Polym; 2014 Jan; 99():720-7. PubMed ID: 24274563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergetic effects of thymoquinone-loaded porous PVPylated Fe
    Kumar SR; Thangam R; Vivek R; Srinivasan S; Ponpandian N
    Nanoscale Adv; 2020 Aug; 2(8):3209-3221. PubMed ID: 36134298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.